Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation

European Journal of Epidemiology

Volumn 28, Issue 1, 2013, Pages 45-53

  Karppi, Jouni ^a   Kurl, Sudhir ^a   Mäkikallio, Timo Heikki ^b   Ronkainen, Kimmo ^a   Laukkanen, Jari Antero ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

Atrial fibrillation; Carotenoids; Elderly population; Oxidative stress; Prevention

Indexed keywords

ALPHA CAROTENE; ANTIHYPERTENSIVE AGENT; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENDER; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RECURRENT DISEASE; RISK ASSESSMENT; SEASONAL VARIATION; SMOKING; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL;

AGED; AGING; ATRIAL FIBRILLATION; BODY MASS INDEX; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUTEIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK; XANTHOPHYLLS;

EID: 84874942609     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9753-z     Document Type: Article

References (28)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5.
2. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-64.
3. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-5.
4. Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB. Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women vs men (the Copenhagen City Heart Study). Am J Cardiol. 2004;94:889-94.
5. Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49:986-92.
6. Zeng X, Li Q, Zhang M, Wang W, Tan X. Green tea may be benefit to the therapy of atrial fibrillation. J Cell Biochem. 2011;112:1709-12.
7. Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem. 2001;1:569-90.
8. Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys. 2001;385:20-7.
9. Lee EH, Faulhaber D, Hanson KM, Ding W, Peters S, Kodali S, et al. Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression. J Invest Dermatol. 2004;122:510-7.
10. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20:46-50.
11. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for practice guidelines and policy conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of pacing and electrophysiology. Circulation. 2001;104:2118-50.
12. Karppi J, Nurmi T, Olmedilla-Alonso B, Granado-Lorencio F, Nyyssönen K. Simultaneous measurement of retinol, alpha-tocopherol and six carotenoids in human plasma by using an isocratic reversed-phase HPLC method. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;867:226-32.
13. Laukkanen JA, Kurl S, Rauramaa R, Lakka TA, Venäläinen JM, Salonen JT. Systolic blood pressure response to exercise testing is related to the risk of acute myocardial infarction in middle-aged men. Eur J Cardiovasc Prev Rehabil. 2006;13:421-8.
14. Räsänen J, Kauhanen J, Lakka TA, Kaplan GA, Salonen JT. Religious affiliation and all-cause mortality: a prospective population study in middle-aged men in Eastern Finland. Int J Epidemiol. 1996;25:1244-9.
15. Deo R, Katz R, Kestenbaum B, Fried L, Sarnak MJ, Psaty BM, et al. Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail. 2010;16:55-60.
16. Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004;43:47-52.
17. Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, Franzosi MG, et al. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am Heart J. 2011;162:382-9.
18. Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension. 2003;41:218-23.
19. Himmelmann A. Hypertension: an important precursor of heart failure. Blood Press. 1999;8:253-60.
20. Liu T, Li L, Korantzopoulos P, Liu E, Li G. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol. 2008;126:160-70.
21. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174-80.
22. McNulty H, Jacob RF, Mason RP. Biologic activity of carotenoids related to distinct membrane physicochemical interactions. Am J Cardiol. 2008;22:20D-9D.
23. Muzakova V, Kand'ar R, Meloun M, Skalicky J, Kralovec K, Zakova P, et al. Inverse correlation between plasma Beta-carotene and interleukin-6 in patients with advanced coronary artery disease. Int J Vitam Nutr Res. 2010;80:369-77.
24. D'Adamo CR, Miller RR, Shardell MD, Orwig DL, Hochberg MC, Ferrucci L, et al. Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture. Clin Nutr. 2012;31:659-65.
25. Di Tomo P, Canali R, Ciavardelli D, Di Silvestre S, De Marco A, Giardinelli A, et al. beta-Carotene and lycopene affect endothelial response to TNF-alpha reducing nitro-oxidative stress and interaction with monocytes. Mol Nutr Food Res. 2012;56:217-27.
26. Milde J, Elstner EF, Grassmann J. Synergistic effects of phenolics and carotenoids on human low-density lipoprotein oxidation. Mol Nutr Food Res. 2007;51:956-61.
27. 2) and free radicals: potential effects for human health. Acta Biochim Pol. 2012;59:27-30.
28. van Het Hof KH, West CE, Weststrate JA, Hautvast JG. Dietary factors that affect the bioavailability of carotenoids. J Nutr. 2000;130:503-6.